Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Interfering with the progression of breast cancer.

Harrington M.

Lab Anim (NY). 2014 Mar;43(3):73. doi: 10.1038/laban.489. No abstract available.

PMID:
24552901
2.

Overexpression of LMO4 induces mammary hyperplasia, promotes cell invasion, and is a predictor of poor outcome in breast cancer.

Sum EY, Segara D, Duscio B, Bath ML, Field AS, Sutherland RL, Lindeman GJ, Visvader JE.

Proc Natl Acad Sci U S A. 2005 May 24;102(21):7659-64. Epub 2005 May 16.

3.

Metastasis-associated protein 1 and its short form variant stimulates Wnt1 transcription through promoting its derepression from Six3 corepressor.

Kumar R, Balasenthil S, Manavathi B, Rayala SK, Pakala SB.

Cancer Res. 2010 Aug 15;70(16):6649-58. doi: 10.1158/0008-5472.CAN-10-0909. Epub 2010 Aug 3.

4.

A functional in vivo screen for regulators of tumor progression identifies HOXB2 as a regulator of tumor growth in breast cancer.

Boimel PJ, Cruz C, Segall JE.

Genomics. 2011 Sep;98(3):164-72. doi: 10.1016/j.ygeno.2011.05.011. Epub 2011 Jun 13.

5.

Reduced tumorigenesis in mouse mammary cancer cells following inhibition of Pea3- or Erm-dependent transcription.

Firlej V, Ladam F, Brysbaert G, Dumont P, Fuks F, de Launoit Y, Benecke A, Chotteau-Lelievre A.

J Cell Sci. 2008 Oct 15;121(Pt 20):3393-402. doi: 10.1242/jcs.027201. Epub 2008 Sep 30.

6.

Dual roles of the transcription factor grainyhead-like 2 (GRHL2) in breast cancer.

Werner S, Frey S, Riethdorf S, Schulze C, Alawi M, Kling L, Vafaizadeh V, Sauter G, Terracciano L, Schumacher U, Pantel K, Assmann V.

J Biol Chem. 2013 Aug 9;288(32):22993-3008. doi: 10.1074/jbc.M113.456293. Epub 2013 Jun 29.

7.

Expression of an engrailed-LMO4 fusion protein in mammary epithelial cells inhibits mammary gland development in mice.

Wang N, Kudryavtseva E, Ch'en IL, McCormick J, Sugihara TM, Ruiz R, Andersen B.

Oncogene. 2004 Feb 26;23(8):1507-13.

PMID:
14676840
8.

Hb9 versus type 2 interneurons.

Ziskind-Conhaim L, Hinckley CA.

J Neurophysiol. 2008 Feb;99(2):1044-6; author reply 1047-9. doi: 10.1152/jn.01163.2007. No abstract available.

9.

Msx-1 and Msx-2 in mammary gland development.

Satoh K, Ginsburg E, Vonderhaar BK.

J Mammary Gland Biol Neoplasia. 2004 Apr;9(2):195-205. Review.

PMID:
15300013
10.

Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop.

Aceto N, Sausgruber N, Brinkhaus H, Gaidatzis D, Martiny-Baron G, Mazzarol G, Confalonieri S, Quarto M, Hu G, Balwierz PJ, Pachkov M, Elledge SJ, van Nimwegen E, Stadler MB, Bentires-Alj M.

Nat Med. 2012 Mar 4;18(4):529-37. doi: 10.1038/nm.2645.

PMID:
22388088
11.

EN2 is a candidate oncogene in human breast cancer.

Martin NL, Saba-El-Leil MK, Sadekova S, Meloche S, Sauvageau G.

Oncogene. 2005 Oct 20;24(46):6890-901.

PMID:
16007149
12.

Heart disease: an ongoing genetic battle?

Srivastava D.

Nature. 2004 Jun 24;429(6994):819-22. No abstract available.

PMID:
15215849
13.

Pituitary homeobox 2 in thyroid tumorigenesis: extension from its classical developmental role.

Xing M.

Cell Cycle. 2010 Apr 15;9(8):1465. Epub 2010 Apr 15. No abstract available.

PMID:
20421721
14.

Function of PEA3 Ets transcription factors in mammary gland development and oncogenesis.

Kurpios NA, Sabolic NA, Shepherd TG, Fidalgo GM, Hassell JA.

J Mammary Gland Biol Neoplasia. 2003 Apr;8(2):177-90. Review.

PMID:
14635793
15.

Upregulation of DLX5 promotes ovarian cancer cell proliferation by enhancing IRS-2-AKT signaling.

Tan Y, Cheung M, Pei J, Menges CW, Godwin AK, Testa JR.

Cancer Res. 2010 Nov 15;70(22):9197-206. doi: 10.1158/0008-5472.CAN-10-1568. Epub 2010 Nov 2.

16.

MiR203 mediates subversion of stem cell properties during mammary epithelial differentiation via repression of ΔNP63α and promotes mesenchymal-to-epithelial transition.

DeCastro AJ, Dunphy KA, Hutchinson J, Balboni AL, Cherukuri P, Jerry DJ, DiRenzo J.

Cell Death Dis. 2013 Feb 28;4:e514. doi: 10.1038/cddis.2013.37.

17.

Transcription factors, normal myeloid development, and leukemia.

Tenen DG, Hromas R, Licht JD, Zhang DE.

Blood. 1997 Jul 15;90(2):489-519. Review. No abstract available.

18.

Cell fate determination factor Dachshund reprograms breast cancer stem cell function.

Wu K, Jiao X, Li Z, Katiyar S, Casimiro MC, Yang W, Zhang Q, Willmarth NE, Chepelev I, Crosariol M, Wei Z, Hu J, Zhao K, Pestell RG.

J Biol Chem. 2011 Jan 21;286(3):2132-42. doi: 10.1074/jbc.M110.148395. Epub 2010 Oct 11.

19.
20.

Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis.

Wang J, Yang Y, Xia HH, Gu Q, Lin MC, Jiang B, Peng Y, Li G, An X, Zhang Y, Zhuang Z, Zhang Z, Kung HF, Wong BC.

Gastroenterology. 2007 Mar;132(3):1066-76. Epub 2006 Dec 3.

PMID:
17383428
Items per page

Supplemental Content

Write to the Help Desk